"Large collections of electronic patient records have long provided abundant, but under-explored information on the real-world use of medicines. But when used properly these records can provide longitudinal observational data which is perfect for data mining," Duan said. "Although such records are maintained for patient administration, they could provide a broad range of clinical information for data analysis. A growing interest has been drug safety."
In this paper, the researchers proposed two novel algorithms—a likelihood ratio model and a Bayesian network model—for adverse drug effect discovery. Although the performance of these two algorithms is comparable to the state-of-the-art algorithm, Bayesian confidence propagation neural network, by combining three works, the researchers say one can get better, more diverse results.
Since the actual adverse drug effects on a given dataset cannot be absolutely determined, the researchers made use of a simulated observational medical outcomes partnership dataset. They constructed this "dataset" with the predefined adverse drug effects to evaluate their methods.
Experimental results show the usefulness of the proposed pattern discovery method on the simulated dataset by improving the standard baseline algorithm—chi-square—by 23.83 percent.
Duan, whose innovative research on large-scale data mining has applications in the business world as well as many industries, including marketing, social networking and bioinformatics. Whereas most data mining experts search for correlation pairs, he focuses on correlated sets of arbitrary size. His research focuses on correlation search, community detection, and density-based clustering and outlier detection.
Duan holds two doctorates-- one in computer science from the Chinese Academy of Sciences, China, and the other in information systems with an emphasis on data mining from the University of Iowa.
Source: Eurekalert
